Eligo Bioscience News Today

Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- DelveInsights Acne Vulgaris Market Insights report includes a comprehensive understanding of current treatment practices, acne vulgaris...

/PRNewswire/ -- The human microbiome therapeutics market is expected to grow by USD 732.95 million from 2022 to 2027. In addition, the momentum of the market...

Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

InnovationRx is your weekly digest of healthcare news. Sign up!

An interesting, but little-known compliance requirement makes private equity and VC firm employees register as lobbyists.

United States Global Bacteriophages Therapy Market document contains the drivers and restraints for the market that are obtained with the help o...

/PRNewswire/ -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...

Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The